BullFrog AI's Collaboration with Lieber Institute for Brain Development Yields Potentially Groundbreaking Biological Stratification of Brain Expression DataGlobeNewsWire • 01/17/24
BullFrog AI Announces Issuance of Australian Patent Protecting Novel Prodrugs of Mebendazole and Their Use in Treating CancerGlobeNewsWire • 01/16/24
BullFrog AI Launches Preclinical Study to Investigate BF-114's Potential in Battling ObesityGlobeNewsWire • 12/06/23
ASP Isotopes and Bullfrog AI Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TVAccesswire • 10/27/23
BullFrog AI Announces Identification of Novel Potential Drug Targets for Colorectal Cancer Using Its AI-Driven bfLEAP™ PlatformGlobeNewsWire • 10/05/23
BullFrog AI Founder and CEO Vin Singh to Present Company Overview at BioFuture 2023GlobeNewsWire • 09/25/23
BullFrog AI Announces Launch of BullFrog Data Networks™, a Data Insights Tool Powered by the bfLEAP™ PlatformGlobeNewsWire • 09/20/23
BullFrog AI Founder and CEO Vin Singh to Present Company Overview at Maxim Group's Emerging Growth in AI Virtual Tech Conference SeriesGlobeNewsWire • 09/14/23
BullFrog AI Announces Three-Year Global Strategic Partnership with the Lieber Institute for Brain DevelopmentGlobeNewsWire • 09/13/23
BullFrog AI Announces Investor Webinar with CEO and Founder Vin Singh on Thursday, September 14, 2023GlobeNewsWire • 09/07/23
BullFrog AI Technology Licensed from Johns Hopkins University APL Named Finalist in R&D 100 AwardsGlobeNewsWire • 08/23/23
BullFrog AI Announces Issuance of U.S. Patent Protecting Novel Prodrugs of Mebendazole and Their Use in Treating CancerGlobeNewsWire • 07/25/23
Generative AI to drive MedTech industry growth and innovation with failure to adopt key threatProactive Investors • 06/12/23
BullFrog AI CEO Vin Singh to Present at the Gujarati Physicians Convention 2023GlobeNewsWire • 06/09/23